Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Neurology. 2011 Sep 6;77(10):1020; author reply 1020. doi: 10.1212/WNL.0b013e31822946d0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Female
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / pathology*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology*

Substances

  • Antibodies, Monoclonal